ArticleJournal of cardiology cases2025
Mitral isthmus ablation with pulsed field ablation technology through an epicardial approach with the CENTAURI system.
Article in Journal of cardiology cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mitral isthmus (MI) ablation is an essential part of persistent atrial fibrillation (AF) ablation, particularly in redo procedures where pulmonary vein isolation (PVI) is durable, but AF recurs. While radiofrequency (RF) ablation is commonly used, creating a complete MI line can be challenging and associated with significant risks. Pulsed field ablation (PFA) offers a safer alternative, providing tissue selectivity with fewer complications. This case report explores a hybrid endocardial and epicardial approach for PFA of mitral isthmus. Specifically, a 64-year-old woman with recurrent AF underwent a redo-ablation after two prior PVI procedures performed with RF. Electroanatomical mapping of the left atrium was performed using the INTELLAMAP ORION mini-basket catheter (Boston Scientific, Marlborough, MA, USA). Mitral isthmus ablation was attempted with a linear contact force catheter connected to the CENTAURI PFA generator (CardioFocus, Inc., Marlborough, MA, USA). Initial endocardial PFA failed to achieve bidirectional block of the mitral isthmus. Additional RF bursts were deployed to injure Marshall bundle autonomic component since PFA alone is known to be ineffective in achieving nerve damage. The ablation catheter was then advanced into the coronary sinus for epicardial mapping, where a gap in the isthmus was identified. PFA delivered through the epicardium successfully achieved bidirectional block with no complications. Hybrid Learning objective: Mitral isthmus (MI) block in addition to pulmonary vein isolation ablation could be required for treatment of patients with persistent atrial fibrillation and high post-ablation recurrence rates. MI ablation with pulsed field ablation (PFA) technology can address challenges in traditional radiofrequency ablation, particularly in complex redo procedures. PFA based on a hybrid
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.